These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12946310)

  • 1. Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression.
    Sawai N; Persons DA; Zhou S; Lu T; Sorrentino BP
    Mol Ther; 2003 Sep; 8(3):376-84. PubMed ID: 12946310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation.
    Antonchuk J; Sauvageau G; Humphries RK
    Exp Hematol; 2001 Sep; 29(9):1125-34. PubMed ID: 11532354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells.
    Allay JA; Galipeau J; Blakley RL; Sorrentino BP
    Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size.
    Thorsteinsdottir U; Sauvageau G; Humphries RK
    Blood; 1999 Oct; 94(8):2605-12. PubMed ID: 10515864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein.
    Krosl J; Austin P; Beslu N; Kroon E; Humphries RK; Sauvageau G
    Nat Med; 2003 Nov; 9(11):1428-32. PubMed ID: 14578881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4.
    Milsom MD; Woolford LB; Margison GP; Humphries RK; Fairbairn LJ
    Mol Ther; 2004 Nov; 10(5):862-73. PubMed ID: 15509504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors.
    Persons DA; Allay JA; Bonifacino A; Lu T; Agricola B; Metzger ME; Donahue RE; Dunbar CE; Sorrentino BP
    Blood; 2004 Feb; 103(3):796-803. PubMed ID: 12920024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness.
    Hong SH; Yang SJ; Kim TM; Shim JS; Lee HS; Lee GY; Park BB; Nam SW; Ryoo ZY; Oh IH
    Stem Cells; 2014 May; 32(5):1313-22. PubMed ID: 24446131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells.
    Lu SJ; Feng Q; Ivanova Y; Luo C; Li T; Li F; Honig GR; Lanza R
    Stem Cells Dev; 2007 Aug; 16(4):547-59. PubMed ID: 17784829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXB4-induced self-renewal of hematopoietic stem cells is significantly enhanced by p21 deficiency.
    Miyake N; Brun AC; Magnusson M; Miyake K; Scadden DT; Karlsson S
    Stem Cells; 2006 Mar; 24(3):653-61. PubMed ID: 16210402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hoxb4-YFP reporter mouse model: a novel tool for tracking HSC development and studying the role of Hoxb4 in hematopoiesis.
    Hills D; Gribi R; Ure J; Buza-Vidas N; Luc S; Jacobsen SE; Medvinsky A
    Blood; 2011 Mar; 117(13):3521-8. PubMed ID: 21278354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase.
    Belzile JP; Karatzas A; Shiu HY; Létourneau S; Palerme JS; Cournoyer D
    Cancer Gene Ther; 2003 Aug; 10(8):637-46. PubMed ID: 12872145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and independent function for Hoxb4 and Bmi1 in HSC activity.
    Faubert A; Chagraoui J; Mayotte N; Fréchette M; Iscove NN; Humphries RK; Sauvageau G
    Cold Spring Harb Symp Quant Biol; 2008; 73():555-64. PubMed ID: 19022763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4.
    Björnsson JM; Larsson N; Brun AC; Magnusson M; Andersson E; Lundström P; Larsson J; Repetowska E; Ehinger M; Humphries RK; Karlsson S
    Mol Cell Biol; 2003 Jun; 23(11):3872-83. PubMed ID: 12748289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enforced adenoviral vector-mediated expression of HOXB4 in human umbilical cord blood CD34+ cells promotes myeloid differentiation but not proliferation.
    Brun AC; Fan X; Björnsson JM; Humphries RK; Karlsson S
    Mol Ther; 2003 Oct; 8(4):618-28. PubMed ID: 14529835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulatory role of HOXB4 in self-renewal of hematopoietic stem cells - review].
    Zheng CL; Zhou B; Lu M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):647-51. PubMed ID: 17605886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors.
    Roth JC; Alberti MO; Ismail M; Lingas KT; Reese JS; Gerson SL
    Virus Res; 2015 Jan; 196():170-80. PubMed ID: 25479595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.
    Yu H; Neale G; Zhang H; Lee HM; Ma Z; Zhou S; Forget BG; Sorrentino BP
    Blood; 2014 Sep; 124(11):1737-47. PubMed ID: 25082879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential.
    Krosl J; Beslu N; Mayotte N; Humphries RK; Sauvageau G
    Immunity; 2003 Apr; 18(4):561-71. PubMed ID: 12705858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients.
    Davis BM; Reese JS; Lingas K; Gerson SL
    J Hematother Stem Cell Res; 2003 Aug; 12(4):375-87. PubMed ID: 12965075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.